People with HIV have about a two-fold increased risk of cardiovascular disease and develop the disease about a decade earlier than the general population.
People with HIV have about a two-fold increased risk of cardiovascular disease and develop the disease about a decade earlier than the general population.
HIVMA is excited to congratulate Robyn Neblett Fanfair, MD, MPH, on her appointment as the permanent director of the Centers for Disease Control and Prevention’s Division of HIV Prevention.
Dr. Adaora Adimora exemplified the difference a single person can make in the world. She was an extraordinary leader, infectious diseases physician, researcher, mentor, advocate and colleague committed to addressing the drivers of HIV-related health disparities with a special focus on women.
The dramatic increase in cases — 755% between 2012 and 2021 — represents missed opportunities in the health care system and the need for more resources at the local, state and federal levels.
The HIV Medicine Association is pleased to recognize three members during IDWeek 2023 for their contributions to advancing the field of HIV medicine.
The HIV Medicine Association is pleased to announce Allison Agwu, MD, ScM, FAAP, FIDSA, as its new chair. The Association also elected a new vice chair and named five new directors. HIVMA addresses health disparities and inequities in its mission to end the HIV epidemic.
The Infectious Diseases Society of America and the HIV Medicine Association welcome the U.S. Preventive Services Task Force’s updated statement reaffirming and expanding its Grade A recommendation for pre-exposure prophylaxis for the prevention of HIV among adolescents and adults.
The Senate’s FY 2024 Labor, Health and Human Services and State and Foreign Operations appropriations bills largely flat fund ID programs at FY 2023 levels and provide a few modest increases.
IDSA is disappointed that the House Labor, Health and Human Services Subcommittee did not fund the Bio-Preparedness Workforce Pilot Program in its FY 2024 appropriations bill, missing an opportunity to close the widening ID workforce gap.
Dr. Marrazzo is an exceptional infectious diseases physician, leader, mentor and scientist who has dedicated her career to key areas of research, including sexually transmitted infections, HIV and antimicrobial resistance.
HIVMA is encouraged by the Senate FY 2024 Labor, Health and Human Services funding bill advanced by the Appropriations Committee, which sustains critical investments in the Ryan White HIV/AIDS Program, the Ending the HIV Epidemic in the U.S. initiative, and the Centers for Disease Control and Prevention’s efforts to establish the foundation for a national PrEP program.
Breakthrough research presented at the International AIDS Society’s 2023 Conference on HIV Science in Brisbane, Australia this week demonstrates the significant advances and scientific achievements recently made in HIV science.